deltatrials
Unknown NA INTERVENTIONAL NCT00526318

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

Trial Protocol for the Treatment of Children With High Risk Neuroblastoma (NB2004-HR)

Sponsor: German Society for Pediatric Oncology and Hematology GPOH gGmbH

Conditions Neuroblastoma
Interventions autologous hematopoietic stem cell transplantation carboplatin cisplatin cyclophosphamide dacarbazine doxorubicin hydrochloride etoposide phosphate filgrastim ifosfamide iobenguane I 131 isotretinoin melphalan radiation therapy topotecan hydrochloride vincristine sulfate vindesine
Updated 8 times since 2017 Last updated: Jul 15, 2015 Started: Jan 31, 2007 Primary completion: Dec 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Neuroblastoma, this trial is ongoing. The trial is conducted by German Society for Pediatric Oncology and Hematology GPOH gGmbH and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshotRecruiting~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Aug 2023 · 31 months · monthly snapshotUnknown Status~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  4. Aug 2023 — Jul 2024 [monthly]

    Unknown Status NA

  5. Jan 2021 — Aug 2023 [monthly]

    Unknown Status NA

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  2. Aug 2017 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  3. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • German Society for Pediatric Oncology and Hematology GPOH gGmbH
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Aarau, Switzerland , Augsburg, Germany , Basel, Switzerland , Bayreuth, Germany , Berlin, Germany , Biefeld, Germany , Bonn, Germany , Braunschweig, Germany , Bremen, Germany and 55 more locations